NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas

卵泡期 医学 普通外科 内科学
作者
Isabella Albuquerque Pinto Rebello,Vinícius Loures de Oliveira,Luís Felipe Holzwarth Abbud,Tales Aprígio Camargos Ferreira,Ana Paula Aguiar Vidal,Patrícia de Fátima dos Santos Teixeira
出处
期刊:Endocrine-related Cancer [Bioscientifica]
卷期号:31 (2)
标识
DOI:10.1530/erc-23-0185
摘要

Few studies have focused on reclassifying follicular adenomas (FAs) as noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs), but none have been conducted in America or Europe. The aims of this study were to analyze the prevalence of NIFTP reclassified from follicular variant of papillary thyroid carcinomas (FVPTCs) and FAs before NIFTP was defined in the literature, the rate of NIFTP among PTC (papillary thyroid carcinomas) established in real time between 2017 and 2022, and demographic, ultrasonographic, and cytologic characteristics of NIFTPs compared with FVPTCs and FAs. This was a retrospective cohort study of tumors diagnosed as PTCs ( n = 247) and FAs ( n = 144) at a Brazilian hospital. Overall, 13.4% of PTCs and 7% of FAs were reclassified as NIFTPs. The rate of real-time diagnosed NIFTPs among PTC was 12.3%. The median tumor size was larger among NIFTPs (3.0 cm) than FVPTCs (1.1 cm; P < 0.01). A high-risk ultrasonographic pattern was rare in NIFTPs (5.6%). The cytologic classifications differed between FVPTCs and NIFTPs ( P < 0.01), and the most frequent category among NIFTPs was ‘follicular neoplasm’ (52.6%). The category ‘suspicious for malignancy’ was frequent in FVPTCs and rare (5.3%) in NIFTPs. In conclusion, FVPTCs and FAs may be reclassified as NIFTPs. The prevalence of NIFTPs reclassified from FAs was lower in our cohort than in Asian studies. The rate of NIFTPs reclassified from PTC was similar to that of NIFTPs diagnosed in real time and was aligned with rates reported in studies from America and Europe. Preoperative features could not differentiate NIFTPs from FVPTCs or FAs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
msw发布了新的文献求助10
刚刚
Betty发布了新的文献求助10
1秒前
残剑月发布了新的文献求助30
1秒前
lj完成签到,获得积分10
2秒前
松尐发布了新的文献求助10
2秒前
烂漫铃铛完成签到,获得积分10
2秒前
猪猪hero应助沉静白翠采纳,获得10
2秒前
viho发布了新的文献求助10
3秒前
花根发布了新的文献求助10
3秒前
有什么大不了的呢完成签到,获得积分10
3秒前
sober发布了新的文献求助20
4秒前
缓慢的秋莲完成签到 ,获得积分10
4秒前
0222完成签到,获得积分20
4秒前
雨辰完成签到 ,获得积分10
4秒前
NexusExplorer应助科研狗采纳,获得10
5秒前
思源应助典雅的迎波采纳,获得10
5秒前
下文献完成签到,获得积分10
6秒前
clyde凌丫完成签到 ,获得积分10
6秒前
碧蓝的乐荷完成签到,获得积分20
7秒前
科研通AI6应助zjx采纳,获得10
7秒前
青青发布了新的文献求助10
7秒前
zhabgyyy完成签到,获得积分10
7秒前
7秒前
7秒前
陈BB完成签到,获得积分10
7秒前
丘比特应助清秋夜露白采纳,获得10
8秒前
量子星尘发布了新的文献求助10
8秒前
9秒前
科研小白完成签到,获得积分10
9秒前
松尐完成签到,获得积分10
9秒前
seasound完成签到,获得积分10
9秒前
小满发布了新的文献求助10
10秒前
10秒前
flsqw发布了新的文献求助10
10秒前
白鹿完成签到,获得积分20
10秒前
11秒前
11秒前
Betty完成签到,获得积分10
12秒前
佩玖发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Basic And Clinical Science Course 2025-2026 3000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
人脑智能与人工智能 1000
花の香りの秘密―遺伝子情報から機能性まで 800
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5608315
求助须知:如何正确求助?哪些是违规求助? 4692918
关于积分的说明 14876115
捐赠科研通 4717325
什么是DOI,文献DOI怎么找? 2544189
邀请新用户注册赠送积分活动 1509187
关于科研通互助平台的介绍 1472836